Apellis Pharmaceuticals (NASDAQ: APLS) Just Broke Out with High Volume
Our target potential upside is 12% to 21% in the next 3-6 months.
Read MorePosted by Tara Young, Trades Of The Day | May 18, 2021
Our target potential upside is 12% to 21% in the next 3-6 months.
Read MorePosted by Tara Young, Trades Of The Day | May 17, 2021
Our target potential upside is 7% to 16% in the next 4-6 months.
Read MorePosted by Tara Young, Trades Of The Day | May 14, 2021
Our target potential upside is almost 15% to 29% in the next 3-6 months.
Read MorePosted by Tara Young, Trades Of The Day | May 13, 2021
An upmove may be imminent, so we’re targeting a potential upside of 25% to 50% in the next 4-6 months.
Read MorePosted by Tara Young, Trades Of The Day | May 12, 2021
Our target potential upside is 21% to 46% in the next 3-6 months.
Read More